Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?

BJU International

Volumn 96, Issue 3, 2005, Pages 320-323

  Izawa, Jonathan I ^a   Lega, Iliana ^a   Downey, Donal ^a   Chin, Joseph L ^a   Luke, Patrick P ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Carcinogenesis; Prostate neoplasm; Prostatic intraepithelial neoplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; DIGITAL RECTAL EXAMINATION; DISEASE ACTIVITY; DISEASE COURSE; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 23244461838     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05623.x     Document Type: Review

References (25)

1. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Path 2004; 17: 360-79
2. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol 2001; 25: 1079-85
3. Davidson D, Bostwick DG, Qian J et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 1995; 154: 1295-9
4. Shepherd D, Keetch DW, Humphrey PA, Smith DS, Stahl D. Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol 1996; 156: 460-2
5. Mian BM, Naya Y, Okihara K, Vakar-Lopez F, Troncoso P, Babaian RJ. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous extended multisite biopsy. Urology 2002; 60: 836-40
6. Naya Y, Ayala AG, Tamboli P, Babaian RJ. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology 2004; 63: 503-8
7. Emmert-Buck MR, Vocke CD, Pozzatti RO et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995; 55: 2959-62
8. Kim NW, Hruszkewycz AM. Telomerase activity modulation in the prevention of prostate cancer. Urology 2001; 57: 148-53
9. Willman JH, Holden JA. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate. Prostate 2000; 42: 280-6
10. Ge K, Minhas F, Duhadaway J et al. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 2000; 86: 155-61
11. Nasir A, Copeland J, Gillespie JW et al. Preneoplastic lesions of the prostate - clinical, pathological and molecular biological aspects. In Vivo 2002; 16: 557-66
12. Chrouser KL, Lieber MM. Extended and saturation needle biopsy for the diagnosis of prostate cancer. Curr Urol Rep 2004; 5: 226-30
13. Bostwick DG. Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem Suppl 1992; 16H: 10-9
14. Balaji KC, Rabbani F, Tsai H, Bastar H, Fair WR. Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance. J Urol 1999; 162: 753-7
15. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277: 1445-51
16. Lefkowitz GK, Taneja SS, Brown J et al. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol 2002; 168: 1415-8
17. Ferguson J, Zincke H, Ellison E, Bergstrahl E, Bostwick DG. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 1994; 44: 91-5
18. Vailancourt L, Ttu B, Fradet Y et al. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study. Am J Surg Pathol 1996; 20: 86-93
19. Van der Kwast TH, Labrie F, Tetu B. Persistence of high-grade prostatic intraepithelial neoplasia under combined androgen blockade therapy. Hum Pathol 1999; 30: 1503-7
20. Civantos F, Watson RB, Pinto JE et al. Finasteride effect on benign prostatic hyperplasia and prostate cancer. A comparative clinico-pathologic study of radical prostatectomies. J Urol Pathol 1997; 6: 1-8
21. Yang XJ, Lecksell K, Short K et al. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group: Proscar Long-Term Efficacy and Safety Study. Urology 1999; 53: 696-700
22. Montironi R, Pomante R, Diamanti L, Hamilton PW, Thompson D, Bartels PH. Evaluation of prostatic intraepithelial neoplasia after treatment with 5-alpha-reductase inhibitor (finasteride). A methodologic approach. Anal Quant Cytol Histol 1996; 18: 461-70
23. Bostwick DG, Neumann R, Qian J, Cheng L. Reversibility of prostatic intraepithelial neoplasia: implications for chemoprevention. Eur Urol 1999; 35: 492-5
24. Arakawa A, Song S, Scardino PT, Wheeler TM. High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma. Pathol Res Pract 1995; 191: 868-72
25. Gaudin PB, Zelefsky MJ, Leibel SA, Fuks Z, Reuter VE. Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 1999; 23: 1021-31